e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Assessing respiratory function: QA and specific applications
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Acceptability of a wide range of inhalation resistances in patients with COPD
J. van der Palen, M. M. Eijsvogel, B. F. Kuipers, M. Schipper, N. A. Vermue (Enschede, Zwolle, Utrecht, Zeist, Netherlands)
Source:
Annual Congress 2005 - Assessing respiratory function: QA and specific applications
Session:
Assessing respiratory function: QA and specific applications
Session type:
Thematic Poster Session
Number:
1160
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. van der Palen, M. M. Eijsvogel, B. F. Kuipers, M. Schipper, N. A. Vermue (Enschede, Zwolle, Utrecht, Zeist, Netherlands). Acceptability of a wide range of inhalation resistances in patients with COPD. Eur Respir J 2005; 26: Suppl. 49, 1160
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Specific inhalation challenge testing in consecutive patients with a wide range of occupational agents
Source: International Congress 2017 – Asthma: clinical and epidemiologic characterisation
Year: 2017
Assessment of satisfaction with inhalation devices in COPD patients
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012
Interindividual variability of peak inhalation rate through different inhalers by asthmatic children and adults and those with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 133s
Year: 2001
Reproducibility of inhaler use and pulmonary drug deposition in COPD
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016
Investigation of breathing parameters of COPD patients inhaling through three different DPI devices
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016
Assessment of the technique in different inhalation devices and investigating the factors associated with inhaler misuse in COPD patients
Source: International Congress 2017 – Pulmonary drug and devices delivery
Year: 2017
Tolerability of inhalation of salt particles in COPD patients
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020
The influence of type of inhalation device on adherence of COPD patients to inhaled medication
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Evaluation of the individual bronchodilator response in patients with severe COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 246s
Year: 2002
Assessing the incidence pattern of pneumonia among COPD patients with or without exposure to inhaled steroids
Source: Annual Congress 2007 - Epidemiology of COPD
Year: 2007
What influences the response to training of inhalation technique in patients with asthma and COPD?
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018
Efficacy of inhalation from different powder inhalators in COPD patiens with chronic respiratory failure
Source: Eur Respir J 2006; 28: Suppl. 50, 210s
Year: 2006
Late Breaking Abstract - Explore the effective dose of bronchodilator nebulization via high flow nasal cannula in adult COPD and asthma patients
Source: International Congress 2018 – New pharmacological strategies in airway diseases
Year: 2018
Postbronchodilator response of small airways after 800 microgrammes of salbutamol in COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Does the inhalation device affect the bronchodilatory dose response curve of Salbutamol in asthma- and COPD patients?
Source: Eur Respir J 2003; 22: Suppl. 45, 473s
Year: 2003
Non-contact assessment of acute bronchodilator’ response during tidal breathing in COPD patients using structured light plethysmography (SLP)
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015
A realistic study assessing inhaled treatment compliance in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept